Aspire BioPharma, Inc. (ASBP) — Cash Flow Quality Index
Aspire BioPharma, Inc. (ASBP) has a Cash Flow Quality Index of -0.10x as of June 2023. Operating cash flow of $-189.95K is below net income of $1.81 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore ASBP total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aspire BioPharma, Inc. Cash Flow Quality Index (2022–2023)
Historical Cash Flow Quality Index for Aspire BioPharma, Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ASBP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Aspire BioPharma, Inc. (2022–2023)
Year-by-year earnings quality comparison for Aspire BioPharma, Inc.. For live market cap and the full company financial profile, see ASBP stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.15x | $-653.11K | $4.46 Million | ▲ +65.3% |
| 2022 | -0.42x | $-1.41 Million | $3.34 Million | — |